Print Friendly, PDF & Email

NCT/Study#

NA /

M20-866

A Phase 1b Dose Escalation Study Of Lemzoparlimab (TJ011133) In Combination With Azacitidine And/Or Venetoclax In Subjects With Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS Azacitidine And/Or Venetoclax In Subjects With Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS

DISEASE GROUP:
Leukemia
current phase:
Phase I
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: